Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conference:
- Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the 31st Annual Piper Jaffray Healthcare Conference in New York, NY, on Wednesday, December 4, 2019, at 9:30 AM (ET). The presentation, which will occur live at the Lotte New York Palace, will be concurrently webcast.
The link to the webcast will be available on the Dexcom IR website at investors.dexcom.com by navigating to “Events and Presentations.”
About DexCom, Inc.
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191126005235/en/
Dexcom Inc. Aktie
Hohe Buy- und niedrige Sell-Zahlen bei Dexcom Inc. zeigen ein stark positives Sentiment.
Für Dexcom Inc. ergibt sich ein Potenzial von -3.35%, selbst wenn das Kursziel von 75 € unter dem aktuellen Kurs von 77.6 € liegt.
